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ABSTRACT
Glucocorticoid receptor-like immunoreactiv-
ity (GCRI) was found in the normal pituitary
pars intermedia (PI) when immunohistochem.
istry was used. Since in previous studies we de-
scribed two kinds of cells in the denervated
(grafted) PI, i.e., "light cells" (overactive cells
which do not contain detectable melanocyte.
stimulating hormone) and "dark cells" (hypo.
active cells which contain the hormone), it was
decided to investigate whether different patterns
of distribution of the receptors could be detected
in the glared gland when compared with the
intact PI. Intact glands showed the receptors
located in the nucleus. In transplanted glands, it
was observed that light cells showed receptors in
both the nuclei and the cytoplasm; on the other
hand, dark cells displayed them in the nuclei
only, as is the case in all cells of the normal PI.
We had previously interpreted dark cells as
dopamine-indifferent whereas light cells were
considered dopamine-sensitive. The changes in
the distribution of GCR after denervation by
grafting, which only affected the light cells,
support the view of other authors that GCR of
the pars intermedia are under the influence of
dopamine and reinforce our opinion that dark
cells are dopamine-indifferent.
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So far, only two groups have investigated by
immunohistochemistry the presence of
glucocorticoid receptors (GCR) in the normal
pars intermedia (PI). Each group concluded with
opposing results, i.e., Antakly et al. could not
dete_rmJne the existence of GCR /1,2/ whereas
Bertini et al. found them/4/; however, authors
agree that decentralization of the PI induces the
development of such receptors due to the
absence of dopaminergic innervation [3,9/.
In previous studies/6/we described two kinds
of cells in the denervated (grafted) PI, i.e., "light
cells" (overactive cells which do not contain
detectable melanocyte-stimulating hormone
[MSH] and "dark cells" (hypoactive cells which
contain the hormone). Thus it was decided to
investigate whether different patterns of
distribution of the receptors could be detected in
the grafted gland when compared with the intact
PI.
MATERIALSAND METHODS
Normal. adult male and female Sprague-
Dawley rats were used. Twenty normal pitu-
itaries and nine neurointermediate lobes, which
were decentralized by gaffing them beneath the
kidney capsule for 20 days, were studied. Glands
were fixed in Elftman’s fluid/5/for 3 h and em-
bedded in paraffin. Normal glands were inves-
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tigated only for glucocorticoid receptor-like
immunoreactivity (GCRI). Transplants were
treated, first, for the demonstration of GCRI
and, secondly, for c-MSH. Both antigens were
detected using the peroxidase-antiperoxidase
immunohistochemical procedure (PAP) of
Sternberger/10/. 3-Amino-9-ethylcarbazole was
used as oxygen accepter to locate GCRI and 3,3’-
diaminobenzidine was used for MSH. In order to
detect the two antigens separately, sections were
stained, photographed and destained in graded
alcohol concentrations; antibodies were de-
tached with 3 M ammonium thiocyanate (over-
night)/8/. Finally, the same sections were stained
for MSH and photographed again. To stain the
receptors we used a first monoclonal antibody
against Type II GCR generated against rat liver
GCR/12/. This antibody, called 1 GR 49/4, was
generously supplied by Dr. H.M. Westphal
(Institut ftir Molekularbiologie und Tumor-
forschung, Marburg, Germany). Details on its
preparation and specificity have been published
elsewhere /13/. Antibodies were used diluted
1:30-50. MSH was demonstrated with an anti-
serum kindly supplied by Dr. A. Eberle
(Research Department, University Hospital,
Basel, Switzerland), directed against the C-
terminal portion of the a-MSH molecule which
fully cross-reacts with diacetylated and
deacetylated MSHs showing a very. low cross-
reaction with ACTH (1-39) and analogs (less
than 0.03%)/7/; antiserum dilution was 1:800.
Both second antibody and PAP solution were
purchased at Sigma (St. Louis, USA). The
solution to dilute all antibodies was PBS
containing 2.5% Triton X 100.
To test the specificity of the immuno-
histochemical reaction for GCR the following
controls were performed: (a) one of the steps of
the immunohistochemical reaction was omitted
and, (b) unspecific mouse ascitic fluid was used
instead of the primary antibodies.
RESULTS
By using this antiserum the presence of GCRI
in normal rats could be determined in every
nucleus of the PI cells (Fig. 1). Cytoplasmic
staining was not observed. In grafted glands,
nuclei preserved their staining property;
nevertheless, a marked difference could be seen
after comparing light and dark cell cytoplasm. As
described in our previous paper /6/, MSH-
staining made it possible to differentiate cells
containing granules of the hormone (dark cells)
from cells devoid of granules (light cells) (Fig. 3).
While light cells showed the presence of GCRI
in their cytoplasm after grafting, dark cells
remained with a GCRI pattern similar to that of
non-transplanted glands (Fig. 2). Controls did
not stain at all.
A section from the pituitary of a normal rat
stained for GCR. In the pars intermedla (Pl),
nuclei, but not cytoplasm, appear positively
stained. In the pars distalis (PD) the reaction
is stronger and cells displaying either
positive (P) or negative (arrow heads)
stained cytoplasm are depicted, x 150
DISCUSSION
Using the same antiserum as the one used by
Bertini et al./4/, we corroborated their findings,
namely that the PI actually contains GCRI. As
expected, and according to a current view in the
field of GCR/11/, they were present in the cell
nucleus. Our observations and those of Bertini et
al. /4/ are not in accordance with the ones of
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Fig, 2: A section from a transplanted pars
intermedla. All cells display nuclear GCRI.
Notice that cells marked 1, 2, 3, 4 and 5 do
not show GCRI in the cytoplasm, whereas
other cells, distributed among them, do (LC).
x 400
Fig. 3: The same section as shown in Fig. 2 stained
for -MSH. Dark cells (1, 2, 3, 4, 5) can be
seen. Notice that these cells are the ones
that in Fig. 2 do not contain receptors in the
cytoplasm; the others, unstained, are light
cells (LC) and contain cytoplasm receptors
in Fig. 2. x 400
Antakly et aL/1,2/, who could not determine the
existence of the receptors in the normal PI. The
reason for the discrepancy might be that the
monoclonal antibodies used by us were more
sensitive and specific for GCR. Furthermore, we
did not prepare cryostat sections since paraffin
sections were suitable for the immunostaining;
presumably, we succeeded in the staining either
because we used Elftman’s fixative/5/or because
the concentration at which the first antibody was
used was relatively high.
When Bertini et al. /4/ investigated GCRI with
the electron microscope, they observed that
some of the receptors were located in the
cytoplasm of the normal PI as well. In our light
microscope specimens we could not observe
such a localization in the normal gland (indeed,
electron microscopy should be more sensitive for
the reaction products), but we did in light cells of
the grafted PI, thus indicating that there was an
appreciable increase of receptors in these cells
after denervation of the gland. Whether this
increase expresses a modification in the well-
known traffic of receptors from the cytoplasm to
the nucleus, or corresponds to an increase in
receptor synthesis has not yet been ascertained.
We have previously published/6/that, after
cessation of dopamine innervation, cells of the PI
differentiate into two kinds, i.e., light cells, which
were deprived of MSH storage and showed signs
of hyperactivation, and dark cells, containing
MSH-secretory granules. Light cells were
interpreted as dopamine sensitive, whereas dark
cells were considered dopamine indifferent;
furthermore, we have suggested /7/ that light
cells in the grafts secrete ACqT-/ or AC"I
analogs instead of MSH; on the other hand, we
thought that dark cells possess little or no
secretory activity. The development of GCRI in
the cytoplasm of the dopamine sensitive light
cells speaks in favor of a dependence between
dopamine and GCRI in the PI, as published by
other authors, who, however, did not detect two
cell kinds in the graft/3,9/; moreover, the present
observations would reinforce our previous
opinion/6/that dark cells, herein described as
not showing appreciable changes in the
distribution of GCRI after denervation, are
dopamine indifferent.
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